Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Dr. Cheryl Blanchard was appointed President and CEO of Anika Therapeutics, after serving as interim CEO. Anika specializes in the development, manufacture and commercialization of therapeutic pharmaceuticals and medical devices. Cheryl brings to her role extensive experience in pre-clinical, clinical, and commercial development of advanced, game-changing products in biologics, drug delivery and medical devices. Prior to her work as an executive officer with Anika, she served as the president and CEO of Microchips Biotech, Inc., a venture-backed biotechnology company developing regenerative medicine and drug delivery products, from 2014 until its sale to Daré Bioscience. Cheryl has also been a Principal at Blanchard Consulting, LLC which provides scientific, regulatory, and business strategy consulting services to medical device companies and private equity clients. She holds 32 patents and is a member of the National Academy of Engineering. She received a BS degree from Alfred University and M.S. and Ph.D. degrees from the University of Texas at Austin.
